ACUMEN PHARMACEUTICALS INC (ABOS) Stock Income Statement
NASDAQ:ABOS - Nasdaq - US00509G2093 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 1.44M | 1.70M | |||
| Operating Expenses | 61.14M | 45.24M | 19.58M | 9.35M | 9.50M | |||
| Research and Development | 42.32M | 32.36M | 12.31M | 8.00M | 8.58M | |||
| Selling, General, and Administrative Expenses | 18.82M | 12.88M | 7.28M | 1.35M | 930.00K | |||
| Operating Income | -61.14M | -45.24M | -19.58M | -7.91M | -7.81M | |||
| Interest Income/Expense | 8.85M | 2.39M | 80.00K | 0.00 | 50.00K | |||
| Other Income/Expense | -83.00K | -10.00K | -81.11M | 590.00K | -150.00K | |||
| Income Before Taxes | -52.37M | -42.86M | -100.61M | -7.33M | -7.91M | |||
| Net Income | -52.37M | -42.86M | -100.61M | -7.33M | -7.69M | |||
| EBITDA | -61.08M | -45.21M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.08 | -1.06 | -5.02 | -0.19 | -0.20 | |||
| Non GAAP EPS | -1.08 | -1.06 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -509.03% | -452.35% | |||
| Operating Profit Margin | N/A | N/A | N/A | -549.31% | -459.41% | |||
All data in USD